Skip to main content

2 Result(s)

within Bingyang Hu Remove this filter Surgery Remove this filter

and

  1. Article

    Open Access

    Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors

    It is controversial whether patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) should undergo salvage surgery following the combination therapy of tyrosine kinase inhibitors (T...

    Tianyu Jiao, Haowen Tang, Wenwen Zhang, Bingyang Hu, Tao Wan, Yinbiao Cao… in BMC Surgery (2023)

    Download PDF (3246 KB) View Article

  2. No Access

    Article

    Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence

    Hepatocellular carcinoma (HCC) is characterized by a high recurrence rate and poor prognosis. In recent years, the therapeutic regimen of programmed cell death protein 1 (PD-1) antibody combined with multi-tar...

    Huizhong Shi, Wenwen Zhang, Bingyang Hu, Yafei Wang, Ze Zhang… in Hepatology International (2023)